Physicochemical Stability and Compatibility Testing of Voriconazole in All-in-One Parenteral Nutrition Admixtures

(1) Drug compatibility with all-in-one (AiO) parenteral nutrition (PN) admixtures is a very important pharmaceutical quality issue to be answered based on appropriate laboratory testing. We assessed voriconazole (V), a poorly water-soluble (logP ≈ 1) single-daily dosed antifungal drug monitored in p...

Full description

Bibliographic Details
Main Authors: Emilie Reber, Peter Neyer, Katja A. Schönenberger, Christoph Saxer, Luca Bernasconi, Zeno Stanga, Andreas Huber, Angelika Hammerer-Lercher, Stefan Mühlebach
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/13/9/1447
_version_ 1797517603718037504
author Emilie Reber
Peter Neyer
Katja A. Schönenberger
Christoph Saxer
Luca Bernasconi
Zeno Stanga
Andreas Huber
Angelika Hammerer-Lercher
Stefan Mühlebach
author_facet Emilie Reber
Peter Neyer
Katja A. Schönenberger
Christoph Saxer
Luca Bernasconi
Zeno Stanga
Andreas Huber
Angelika Hammerer-Lercher
Stefan Mühlebach
author_sort Emilie Reber
collection DOAJ
description (1) Drug compatibility with all-in-one (AiO) parenteral nutrition (PN) admixtures is a very important pharmaceutical quality issue to be answered based on appropriate laboratory testing. We assessed voriconazole (V), a poorly water-soluble (logP ≈ 1) single-daily dosed antifungal drug monitored in patients and thus candidate for AiO PN admixing for convenient and safe patient care. We evaluated V compatibility and stability in AiO PN admixtures through adapted therapeutic drug monitoring method (drug stability) and visual microscopic emulsion stability by lipid droplets analysis improved by an automated microscopic digital assessment. (2) V was added in concentrations of 0.05/0.25/0.5 mg/mL (143.1/715.7/1431.5 µM), correlating to daily therapeutic dosing, to three commercially available industrial AiO PN admixtures. Three aliquots were stored in the refrigerator (4 °C), at room temperature (24 °C) and under stress conditions in a water bath (37 °C). Samples taken at 0/24/48/72/168 h after admixing were subjected to a stability-indicating one-week analysis. Assessment included visual examination, lipid droplet measurement according to an established and validated method (bright-field microscopy using oil immersion), pH measurement (glass electrode) and V identification/quantification (LC–MS/MS). (3) After one week, all samples at 37 °C showed slight yellow discoloration. The pH values remained stable. All samples met specifications for lipid droplets according to size (upper size ≤8 µm, mean size <4.5 ± 2 µm) and number (<i>n</i> ≤ 9 lipid droplets >5 µm). V concentrations were within an acceptable range, calculated for every timepoint as percent of the theoretical concentration spiked into the AiO PN. The median recovery was 98.2% (min–max, 90–112%). (4) At therapeutic doses, commercial V formulations were compatible and stable within specifications over one week in commonly used volumes of commercial AiO PN admixtures at 4–37 °C.
first_indexed 2024-03-10T07:18:50Z
format Article
id doaj.art-eccf64b06f3b4ff6805c7a479bf58b81
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-10T07:18:50Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-eccf64b06f3b4ff6805c7a479bf58b812023-11-22T14:47:52ZengMDPI AGPharmaceutics1999-49232021-09-01139144710.3390/pharmaceutics13091447Physicochemical Stability and Compatibility Testing of Voriconazole in All-in-One Parenteral Nutrition AdmixturesEmilie Reber0Peter Neyer1Katja A. Schönenberger2Christoph Saxer3Luca Bernasconi4Zeno Stanga5Andreas Huber6Angelika Hammerer-Lercher7Stefan Mühlebach8Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, SwitzerlandInstitute of Laboratory Medicine, Kantonsspital Aarau, 5001 Aarau, SwitzerlandDepartment of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, SwitzerlandInstitute of Laboratory Medicine, Kantonsspital Aarau, 5001 Aarau, SwitzerlandInstitute of Laboratory Medicine, Kantonsspital Aarau, 5001 Aarau, SwitzerlandDepartment of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, SwitzerlandInstitute of Laboratory Medicine, Kantonsspital Aarau, 5001 Aarau, SwitzerlandInstitute of Laboratory Medicine, Kantonsspital Aarau, 5001 Aarau, SwitzerlandDivision of Clinical Pharmacy and Epidemiology and Hospital Pharmacy, University of Basel, 4031 Basel, Switzerland(1) Drug compatibility with all-in-one (AiO) parenteral nutrition (PN) admixtures is a very important pharmaceutical quality issue to be answered based on appropriate laboratory testing. We assessed voriconazole (V), a poorly water-soluble (logP ≈ 1) single-daily dosed antifungal drug monitored in patients and thus candidate for AiO PN admixing for convenient and safe patient care. We evaluated V compatibility and stability in AiO PN admixtures through adapted therapeutic drug monitoring method (drug stability) and visual microscopic emulsion stability by lipid droplets analysis improved by an automated microscopic digital assessment. (2) V was added in concentrations of 0.05/0.25/0.5 mg/mL (143.1/715.7/1431.5 µM), correlating to daily therapeutic dosing, to three commercially available industrial AiO PN admixtures. Three aliquots were stored in the refrigerator (4 °C), at room temperature (24 °C) and under stress conditions in a water bath (37 °C). Samples taken at 0/24/48/72/168 h after admixing were subjected to a stability-indicating one-week analysis. Assessment included visual examination, lipid droplet measurement according to an established and validated method (bright-field microscopy using oil immersion), pH measurement (glass electrode) and V identification/quantification (LC–MS/MS). (3) After one week, all samples at 37 °C showed slight yellow discoloration. The pH values remained stable. All samples met specifications for lipid droplets according to size (upper size ≤8 µm, mean size <4.5 ± 2 µm) and number (<i>n</i> ≤ 9 lipid droplets >5 µm). V concentrations were within an acceptable range, calculated for every timepoint as percent of the theoretical concentration spiked into the AiO PN. The median recovery was 98.2% (min–max, 90–112%). (4) At therapeutic doses, commercial V formulations were compatible and stable within specifications over one week in commonly used volumes of commercial AiO PN admixtures at 4–37 °C.https://www.mdpi.com/1999-4923/13/9/1447parenteral nutritionvoriconazole stability and compatibilitylipid droplet microscopyLC–MS/MS
spellingShingle Emilie Reber
Peter Neyer
Katja A. Schönenberger
Christoph Saxer
Luca Bernasconi
Zeno Stanga
Andreas Huber
Angelika Hammerer-Lercher
Stefan Mühlebach
Physicochemical Stability and Compatibility Testing of Voriconazole in All-in-One Parenteral Nutrition Admixtures
Pharmaceutics
parenteral nutrition
voriconazole stability and compatibility
lipid droplet microscopy
LC–MS/MS
title Physicochemical Stability and Compatibility Testing of Voriconazole in All-in-One Parenteral Nutrition Admixtures
title_full Physicochemical Stability and Compatibility Testing of Voriconazole in All-in-One Parenteral Nutrition Admixtures
title_fullStr Physicochemical Stability and Compatibility Testing of Voriconazole in All-in-One Parenteral Nutrition Admixtures
title_full_unstemmed Physicochemical Stability and Compatibility Testing of Voriconazole in All-in-One Parenteral Nutrition Admixtures
title_short Physicochemical Stability and Compatibility Testing of Voriconazole in All-in-One Parenteral Nutrition Admixtures
title_sort physicochemical stability and compatibility testing of voriconazole in all in one parenteral nutrition admixtures
topic parenteral nutrition
voriconazole stability and compatibility
lipid droplet microscopy
LC–MS/MS
url https://www.mdpi.com/1999-4923/13/9/1447
work_keys_str_mv AT emiliereber physicochemicalstabilityandcompatibilitytestingofvoriconazoleinallinoneparenteralnutritionadmixtures
AT peterneyer physicochemicalstabilityandcompatibilitytestingofvoriconazoleinallinoneparenteralnutritionadmixtures
AT katjaaschonenberger physicochemicalstabilityandcompatibilitytestingofvoriconazoleinallinoneparenteralnutritionadmixtures
AT christophsaxer physicochemicalstabilityandcompatibilitytestingofvoriconazoleinallinoneparenteralnutritionadmixtures
AT lucabernasconi physicochemicalstabilityandcompatibilitytestingofvoriconazoleinallinoneparenteralnutritionadmixtures
AT zenostanga physicochemicalstabilityandcompatibilitytestingofvoriconazoleinallinoneparenteralnutritionadmixtures
AT andreashuber physicochemicalstabilityandcompatibilitytestingofvoriconazoleinallinoneparenteralnutritionadmixtures
AT angelikahammererlercher physicochemicalstabilityandcompatibilitytestingofvoriconazoleinallinoneparenteralnutritionadmixtures
AT stefanmuhlebach physicochemicalstabilityandcompatibilitytestingofvoriconazoleinallinoneparenteralnutritionadmixtures